Canada markets closed

Cyclacel Pharmaceuticals, Inc. (CYCCP)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
6.26-1.04 (-14.25%)
At close: 04:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
420
420
0
0
0
Operating Expenses
Research Development
19,155
19,155
20,274
14,928
4,759
Selling General and Administrative
6,718
6,718
7,382
7,461
5,877
Total Operating Expenses
25,873
25,873
27,656
22,389
10,636
Operating Income or Loss
-25,453
-25,453
-27,656
-22,389
-10,636
Total Other Income/Expenses Net
-364
-364
1,531
188
913
Income Before Tax
-25,551
-25,551
-25,915
-22,185
-9,681
Income Tax Expense
-2,996
-2,996
-4,717
-3,728
-1,236
Income from Continuing Operations
-22,555
-22,555
-21,198
-18,457
-8,445
Net Income
-22,555
-22,555
-21,198
-18,457
-8,445
Net Income available to common shareholders
-22,756
-22,756
-21,399
-18,658
-12,421